EP287: Heart Attack vs. Heart Failure and the Role of AI

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Dr. Warrick Bishop is a cardiologist, author, and CEO of the Healthy Heart Network based in Hobart, Australia. In this ABC Radio Hobart episode, he discusses the critical differences between heart attack and heart failure, and explores the emerging use of AI diagnostic tools in cardiology. The conversation emphasizes the importance of understanding cardiovascular health to prevent the one heart attack that occurs in Australia every 20 minutes. Key Takeaways: A heart attack occurs when a sudden blockage in a major artery cuts off blood supply to the heart muscle, potentially causing dangerous irregular rhythms and collapse, whereas heart failure is when the heart fails to pump enough blood to adequately supply the body's organs. Heart failure causes fatigue and fluid retention because the body's evolutionary defense mechanisms misinterpret poor heart function as blood loss, triggering the kidneys to retain excess fluid that accumulates in the lungs or legs. Symptoms of heart failure include swollen ankles (typically both legs simultaneously), shortness of breath that worsens with physical activity or lying flat, and difficulty with previously manageable tasks like climbing stairs. Heart failure can develop suddenly with acute shortness of breath requiring emergency care, or develop gradually with symptoms that patients may mistakenly attribute to aging, necessitating GP evaluation and cardiology referral. The heart can fail in two distinct ways: either the squeezing function is impaired or the relaxation function is impaired, requiring proper diagnostic scanning to determine the correct treatment approach. Effective medications exist for treating heart failure, and early identification combined with prompt treatment at optimal doses significantly improves patient outcomes. Approximately 40% of people with dangerous arterial plaques have no symptoms because the blockage doesn't limit blood flow until the plaque ruptures and forms a clot, making many heart attacks seemingly unpredictable. AI diagnostic tools like Clearly are already being used commercially in the US to interpret cardiac scans with high accuracy, potentially saving considerable time compared to manual radiologist review. AI technology could dramatically accelerate the analysis of large volumes of medical scans without fatigue or breaks, offering enormous potential benefits to healthcare efficiency. The AMA's cautious response to AI diagnostic tools reflects the importance of thoroughly understanding how these systems work before widespread clinical adoption, despite their promising capabilities.